Cargando…

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

Detalles Bibliográficos
Autores principales:	Zielinski, Christoph C, Pinto, Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070276/ https://www.ncbi.nlm.nih.gov/pubmed/27843630 http://dx.doi.org/10.1136/esmoopen-2016-000080

Ejemplares similares

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

CSCO joins ESMO Open—Cancer Horizons
por: Zielinski, Christoph C, et al.
Publicado: (2016)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
por: Ohe, Yuichiro, et al.
Publicado: (2017)

Introducing pro and con discussions in ESMO Open—Cancer Horizons
por: Zielinski, C., et al.
Publicado: (2022)

One year of ESMO Open: Cancer Horizons—where are we going from here?
por: Zielinski, Christoph
Publicado: (2017)

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
por: Morgan, Gilberto, et al.
Publicado: (2020)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
por: Lambertini, Matteo, et al.
Publicado: (2019)

ESMO Open: news in breast cancer 2019
por: Lambertini, Matteo
Publicado: (2020)

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
por: Awada, Ahmad, et al.
Publicado: (2019)

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
por: Burke, Patrick W, et al.
Publicado: (2020)

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
por: Banerjee, Susana, et al.
Publicado: (2020)

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

From ESMO 2022
por: Romero, Diana
Publicado: (2022)

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy
por: Preusser, Matthias
Publicado: (2019)

ESMO Open special series on new emerging targets in cancer immunotherapy
por: Lambertini, Matteo
Publicado: (2020)

ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
por: Pentheroudakis, G., et al.
Publicado: (2022)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge and practice questions
por: Rauh, Stefan, et al.
Publicado: (2018)

From ESMO TAT 2021
por: Killock, David
Publicado: (2021)

From the ESMO Congress 2021
por: Sidaway, Peter
Publicado: (2021)

ESMO and WHO: 14 years of working in partnership on cancer control
por: Ullrich, Andreas, et al.
Publicado: (2016)

Applying the ESMO-Magnitude of Clinical Benefit Scale in real life
por: Ciardiello, Fortunato, et al.
Publicado: (2016)

ESMO Copenhagen 2016: a lung cancer ‘grand cru’
por: Douillard, Jean-Yves
Publicado: (2017)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
por: Pavlidis, Nicholas, et al.
Publicado: (2016)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
por: Ladetto, Marco, et al.
Publicado: (2020)

WHO-ESMO collaboration in cancer control: policies into action to save lives
por: Mikkelsen, B., et al.
Publicado: (2022)

ESMO 2017—my personal highlights
por: Kiesewetter, Barbara, et al.
Publicado: (2018)

My personal highlights of ESMO 2016
por: Dediu, M., et al.
Publicado: (2017)

Pain workshop ESMO: Africa (response)
por: Grant, Liz, et al.
Publicado: (2020)

ESMO 2021—highlights in colorectal cancer
por: Weiss, Lukas
Publicado: (2022)

ESMO 2020: highlights in breast cancer
por: Bartsch, Rupert
Publicado: (2021)

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
por: Kreye, G., et al.
Publicado: (2022)

Welcome to Biosensors: A New Open-Access Journal
por: Newman, Jeffrey D.
Publicado: (2011)

COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
por: Castelo-Branco, L., et al.
Publicado: (2022)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

ESMO Leaders Generation Programme: an alumni insight
por: Arruda, Leticia De Mattos, et al.
Publicado: (2018)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rrqc687mk220h532upr4u5nh5b